News
Sanofi's filing relied, in part, on the FDA’s finding of safety and effectiveness for Humalog (insulin lispro injection) to support approval, but also provided Admelog-specific data, including ...
Hosted on MSN1y
Drug manufacturer Eli Lilly says two of its diabetes drugs are in short supply - as millions of patients face weeks of chaosPatients will have a harder time getting their Humalog and Insulin Lispro Injections at wholesalers and pharmacies through the beginning of next month, the company said. In the meantime ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results